3lon
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| + | |||
==HCV NS3-4a protease domain with ketoamide inhibitor narlaprevir== | ==HCV NS3-4a protease domain with ketoamide inhibitor narlaprevir== | ||
<StructureSection load='3lon' size='340' side='right' caption='[[3lon]], [[Resolution|resolution]] 2.20Å' scene=''> | <StructureSection load='3lon' size='340' side='right' caption='[[3lon]], [[Resolution|resolution]] 2.20Å' scene=''> | ||
| Line 5: | Line 6: | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=BME:BETA-MERCAPTOETHANOL'>BME</scene>, <scene name='pdbligand=NNA:(1R,2S,5S)-3-[N-({1-[(TERT-BUTYLSULFONYL)METHYL]CYCLOHEXYL}CARBAMOYL)-3-METHYL-L-VALYL]-N-{(1S)-1-[(1R)-2-(CYCLOPROPYLAMINO)-1-HYDROXY-2-OXOETHYL]PENTYL}-6,6-DIMETHYL-3-AZABICYCLO[3.1.0]HEXANE-2-CARBOXAMIDE'>NNA</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=BME:BETA-MERCAPTOETHANOL'>BME</scene>, <scene name='pdbligand=NNA:(1R,2S,5S)-3-[N-({1-[(TERT-BUTYLSULFONYL)METHYL]CYCLOHEXYL}CARBAMOYL)-3-METHYL-L-VALYL]-N-{(1S)-1-[(1R)-2-(CYCLOPROPYLAMINO)-1-HYDROXY-2-OXOETHYL]PENTYL}-6,6-DIMETHYL-3-AZABICYCLO[3.1.0]HEXANE-2-CARBOXAMIDE'>NNA</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> | ||
<tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">NS3 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=31646 Hepatitis C virus subtype 1a])</td></tr> | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">NS3 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=31646 Hepatitis C virus subtype 1a])</td></tr> | ||
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3lon FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3lon OCA], [http://www.rcsb.org/pdb/explore.do?structureId=3lon RCSB], [http://www.ebi.ac.uk/pdbsum/3lon PDBsum]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3lon FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3lon OCA], [http://pdbe.org/3lon PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=3lon RCSB], [http://www.ebi.ac.uk/pdbsum/3lon PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=3lon ProSAT]</span></td></tr> |
</table> | </table> | ||
__TOC__ | __TOC__ | ||
Revision as of 05:42, 5 August 2016
HCV NS3-4a protease domain with ketoamide inhibitor narlaprevir
| |||||||||||
Categories: Hepatitis c virus subtype 1a | Prongay, A J | Atp-binding | Capsid protein | Envelope protein | Helicase | Hepatitis c virus | Host membrane | Hydrolase | Macrocyclic ketoamide inhibitor | Membrane | Ns3 protease domain | Nucleotide-binding | Rna replication | Serine protease | Transmembrane | Viral protein | Viral protein-inhibitor complex | Virion
